Abstract
Zarife Rexhaj, Besfort Kryeziu, Premtim Rashiti, Pranvera Ibrahimi, Arlind Batalli, Afrim Poniku, Margaritë Gjoka, Michael Y. Henein, Shpend Elezi, Gani Bajraktari
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
10.1016/j.jaut.2020.102433 · 2020
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: A population-based cohort study
10.1016/s0140-6736(20)30854-0 · 2020
Prevalence of SARS-CoV-2 Antibodies in Kosovo-Wide Population-Based Seroepidemiological Study
10.1111/irv.70004 · 2024
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
10.1093/eurheartj/ehaa409 · 2020
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic
10.1016/j.jacc.2020.04.011 · 2020
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: The pandemic response causes cardiac collateral damage
10.1093/eurheartj/ehaa314 · 2020
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
10.1016/s0140-6736(20)31356-8 · 2020
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: A survey by the European Society of Cardiology
2020
Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
10.1016/j.ijcha.2020.100686 · 2021
Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center
10.1016/j.ahj.2020.04.022 · 2020
Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic
10.1002/ehf2.13075 · 2021
Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction
10.3346/jkms.2022.37.e167 · 2022
Impact of the COVID-19 pandemic on interventional cardiology activity in Spain
2022
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: Insights from the ISACS STEMI COVID 19 Registry
10.1186/s12933-020-01196-0 · 2020
Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England
10.1161/circinterventions.120.009654 · 2020
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy
10.1056/nejmc2009166 · 2020
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic
10.1001/jamacardio.2020.3629 · 2020
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: A registry study
10.1016/s2468-2667(20)30188-2 · 2020
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: A registry study
10.1016/s2468-2667(20)30188-2 · doi-reference
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic
10.1001/jamacardio.2020.3629 · doi-reference
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy
10.1056/nejmc2009166 · doi-reference
Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England
10.1161/circinterventions.120.009654 · doi-reference
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: Insights from the ISACS STEMI COVID 19 Registry
10.1186/s12933-020-01196-0 · doi-reference
Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction
10.3346/jkms.2022.37.e167 · doi-reference
Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic
10.1002/ehf2.13075 · doi-reference
Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center
10.1016/j.ahj.2020.04.022 · doi-reference
Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
10.1016/j.ijcha.2020.100686 · doi-reference
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
10.1016/s0140-6736(20)31356-8 · doi-reference
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: The pandemic response causes cardiac collateral damage
10.1093/eurheartj/ehaa314 · doi-reference
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic
10.1016/j.jacc.2020.04.011 · doi-reference
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
10.1093/eurheartj/ehaa409 · doi-reference
Prevalence of SARS-CoV-2 Antibodies in Kosovo-Wide Population-Based Seroepidemiological Study
10.1111/irv.70004 · doi-reference
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: A population-based cohort study
10.1016/s0140-6736(20)30854-0 · doi-reference
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
10.1016/j.jaut.2020.102433 · doi-reference